Avacta Group saw no growth in patent filings and highest growth of 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Avacta Group’s patent filings and grants. Buy the databook here.
Avacta Group has been focused on protecting inventions in Israel(IL) with two publications in Q2 2024
The Israel(IL) Patent Office dominates the patent filings and grants with nearly 50% filings and 50% grants. The Israel(IL), United Kingdom(GB), and United States(US) patent Office are among the top ten patent offices where Avacta Group is filings its patents. Among the top granted patent authorities, Avacta Group has 50% of its grants in Israel(IL) and 50% in United States(US).
Regeneron Pharmaceuticals and Immatics could be the strongest competitors for Avacta Group
For comprehensive analysis of Avacta Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.